Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00220

Related search